Lista de obras -

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.

artículo científico publicado en 2018

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

scientific article published on 28 February 2020

First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013

scientific article published on 22 November 2018

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

artículo científico publicado en 2020

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

artículo científico publicado en 2015

Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population-based study

artículo científico publicado en 2019

Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases.

artículo científico publicado en 2014

Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort

artículo científico publicado en 2018

Natural IgM antibodies in the immune defence against neoehrlichiosis.

artículo científico publicado en 2017

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

artículo científico publicado en 2017

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

scientific article published on 18 November 2019

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

artículo científico

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group

artículo científico publicado en 2016

Serological reactivity to Anaplasma phagocytophilum in neoehrlichiosis patients

artículo científico publicado en 2018

Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis

scientific article published on 08 April 2019

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

artículo científico publicado en 2018

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives

artículo científico publicado en 2018

Lista de obras de

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population-based study

Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases.

Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort

Natural IgM antibodies in the immune defence against neoehrlichiosis.

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group

Serological reactivity to Anaplasma phagocytophilum in neoehrlichiosis patients

Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives